Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common stock, par value $0.001 per share (the "Common Stock")
-
Shares outstanding
-
139M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
24.3M
-
Shares change
-
+3.92M
-
Total reported value, excl. options
-
$45M
-
Value change
-
+$7.66M
-
Put/Call ratio
-
1.71
-
Number of buys
-
32
-
Number of sells
-
-35
-
Price
-
$1.85
Significant Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) as of Q1 2017
100 filings reported holding ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") as of Q1 2017.
ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.3M shares
of 139M outstanding shares and own 17.53% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.59M shares), VANGUARD GROUP INC (3.17M shares), OppenheimerFunds, Inc. (3M shares), QVT Financial LP (2.56M shares), PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. (1.91M shares), STATE STREET CORP (1.14M shares), NORTHERN TRUST CORP (890K shares), PERCEPTIVE ADVISORS LLC (847K shares), GEODE CAPITAL MANAGEMENT, LLC (663K shares), and MILLENNIUM MANAGEMENT LLC (484K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.